Human granulocytic ehrlichiosis agent inhibits superoxide anion generation by human neutrophils

Infection and Immunity

Volumn 68, Issue 12, 2000, Pages 6697-6703

  Mott, Jason ^a   Rikihisa, Yasuko ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOHYDRATE; CYTOCHROME; CYTOCHROME C; FORMYLMETHIONYLLEUCYLPHENYLALANINE; PHORBOL 13 ACETATE 12 MYRISTATE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SUPEROXIDE;

ARTICLE; CELL KILLING; CELL STRAIN HL 60; CHEMOLUMINESCENCE; DOWN REGULATION; EHRLICHIOSIS; ESCHERICHIA COLI; HUMAN; HUMAN CELL; NEUTROPHIL; PRIORITY JOURNAL; SURVIVAL; TICK BORNE DISEASE;

EHRLICHIA; EHRLICHIOSIS; HL-60 CELLS; HUMANS; NEURAMINIDASE; NEUTROPHILS; PRONASE; PROTEIN BIOSYNTHESIS; SUPEROXIDES; TETRADECANOYLPHORBOL ACETATE;

EID: 0034442469     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.68.12.6697-6703.2000     Document Type: Article

References (27)

1. Babior, B. 1999. NADPH oxidase: an update. Blood 93:1464-1476.
2. Baca, O. G., M. J. Roman, R. H. Glew, R. F. Christner, J. E. Buhler, and A. S. Aragon. 1993. Acid phosphatase activity in Coxiella burnetii: a possible virulence factor. Infect. Immun. 61:4232-4239.
3. Baliga, B. S., A. W. Pronczuk, and H. N. Munro. 1969. Mechanism of cycloheximide inhibition of protein synthesis in a cell-free system prepared from rat liver. J. Biol. Chem. 244:4480-4489.
4. phox. J. Immunol. 164:3946-3949.
5. Chen, S. M., J. S. Dumler, J. S. Bakken, and D. H. Walker. 1994. Identification of a granulocytotropic Ehrlichia species as the etiologic agent of human disease. J. Clin. Microbiol. 32:589-595.
6. Chopra, I., P. M. Hawkey, and M. Hinton. 1992. Tetracyclines, molecular and clinical aspects. J. Antimicrob. Chemother. 29:245-277.
7. Cohen, M. S. 1994. Molecular events in the activation of human neutrophils for microbial killing. Clin. Infect. Dis. 18:170-179.
8. Dahlgren, C., G. Briheim, and O. Stendahl. 1984. Measurement of luminol-dependent leukocyte chemiluminescence originated from intracellular and extracellular events, p. 335-338. In L. J. Kricka, P. E. Stanley, G. H. G. Thorpe, and T. P. Whitehead (ed.), Annals of Applied Bioluminescence Chemiluminescence: Proceedings Academic Press, N.Y.
9. DeLeo, F. R., L.-A. H. Allen, M. Apicella, and W. N. Nauseef. 1999. NADPH oxidase activation and assembly during phagocytosis. J. Immunol. 163:6732-6740.
10. Goodman, J. L., C. M. Nelson, M. B. Klein, S. F. Hayes, and B. W. Weston. 1999. Leukocyte infection by the granulocytic ehrlichiosis agent is linked to expression of a selectin ligand. J. Clin. Investig. 103:407-412.
11. Jacob, T., J. C. Escallier, M. V. Sanguedolce, C. Chicheportiche, P. Bongrand, C. Capo, and J. L. Mege. 1994. Legionella pneumophila inhibits superoxide generation in human monocytes via the down-modulation of a and b protein kinase C isotypes. J. Leukoc. Biol. 55:310-312.
12. Johnston, R. B. 1981. Secretion of superoxide anion, pp. 489-497. In D. O. Adams, P.O. Edelson, and H. Koren (ed.), Methods for studying mononuclear phagocytes. Academic Press, New York, N.Y.
13. Karlsson, A., M. Markfjall, N. Stromberg, and C. Dahlgren. 1995. Escherichia coli-induced activation of neutrophil NADPH-oxidase: lipopolysaccharide and formylated peptides act synergistically to induce release of reactive oxygen metabolites. Infect. Immun. 63:4604-4612.
14. Kim, H.-Y., and Y. Rikihisa. 2000. Expression of interleukin-1β, tumor necrosis factor-alpha, and interleukin-6 in human peripheral blood leukocytes exposed to viable human granulocytic ehrlichiosis agent or recombinant major surface antigen P44. Infect. Immun. 68:3394-3402.
15. Mott, J., R. Barnewall, and Y. Rikihisa. 1999. Human granulocytic ehrlichiosis agent and Ehrlichia chaffeensis reside in different cytoplasmic compartments in HL-60 cells. Infect. Immun. 67:1368-1378.
16. Naids, F. L., and R. F. Rest. 1991. Stimulation of human neutrophil oxidative metabolism by nonopsonized Neisseria gonorrhoeae. Infect. Immun. 59:4383-4390.
17. Park, J., and Y. Rikihisa. 1991. Inhibition of Ehrlichia risticii growth in murine peritoneal macrophage by gamma interferon, calcium ionophore, and concanavalin A. Infect. Immun. 59:3418-3423.
18. Rikihisa, Y. 1991. The tribe Ehrlichieae and ehrlichial diseases. Clin. Microbiol. Rev. 4:286-308.
19. Rikihisa, Y., N. Zhi, G. P. Wormser, B. Wen, H. M. Horowitz, and K. E. Hechemy. 1997. Ultrastructural and antigenic characterization of granulocytic ehrlichia directly isolated and cultivated from a patient in New York State. J. Infect. Dis. 175:210-213.
20. Steinbeck, M. J., J. M. Robinson, and M. J. Karnovsky. 1991. Activation of the neutrophil NADPH-oxidase by free fatty acids requires the ionized carboxyl group and partitioning into membrane lipid. J. Leukoc. Biol. 49: 360-368.
21. 2. Infect. Immun. 57:1108-1112.
22. Terada, L. S., K. A. Johansen, S. Nowbar, A. I. Vasil, and M. L. Vasil. 1999. Pseudomonas aeruginosa hemolytic phospholipase C suppresses neutrophil respiratory burst activity. Infect. Immun. 67:2371-2376.
23. Vazquez-Torres, A., Y. Xu, J. Jones-Carson, D. W. Holden, S. M. Lucia, M. C. Dinauer, P. Mastroeni, and F. C. Fang. 2000. Salmonella pathogenicity island 2-dependent evasion of the phagocyte NADPH oxidase. Science 287: 1655-1658.
24. Visser, L. G., E. Seijmonsbergen, P. H. Nibbering, P. J. van den Broek, and R. van Furth. 1999. Yops of Yersinia enterocolitica inhibit receptor-dependent superoxide anion production by human granulocytes. Infect. Immun. 67:1245-1250.
25. Woodward, M. P., W. W. Young, Jr., and R. A. Bloodgood. 1985. Detection of monoclonal antibodies specific for carbohydrate epitopes using periodate oxidation. J. Immunol. Methods 78:143-153.
26. Yoshiie, K., H.-Y. Kim, J. Mott, and Y. Rikihisa. 2000. Intracellular infection by human granulocytic ehrlichiosis agent inhibits human neutrophil apoptosis. Infect. Immun. 68:1125-1133.
27. Zhi, N., N. Ohashi, Y. Rikihisa, H. W. Horowitz, G. P. Wormser, and K. Hechemy. 1998. Cloning and expression of the 44-kilodalton major outer membrane protein gene of the human granulocytic ehrlichiosis agent and application of the recombinant protein to serodiagnosis. J. Clin. Microbiol. 36:1666-1673.